What Happened?
Raleigh, NC-based ProPharma-Group Appointed Karl Deonanan as Chief Financial Officer
About the Company
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the complete product lifecycle through an advise-build-operate model. Our end-to-end suite of consulting solutions de-risk and accelerate high-profile drug and device programs, ultimately improving patient health and safety. Discover how ProPharma can help you inspire the future of science!
About the Person
Karl Deonanan is Chief Financial Officer at ProPharma Group. Previously, Karl held various senior HR leadership roles in the industry.
Info Source
Press Release
Short Profile